How Long Does Semaglutide Last in the Body and in Practice?

Semaglutide's half-life is approximately one week, which underpins the once-weekly dosing schedule for Wegovy
Weight-loss benefits typically build over months; the STEP 1 trial ran for 68 weeks and recorded an average reduction of around 15% of body weight at the 2.4 mg maintenance dose
Effects on appetite and weight generally reverse after stopping treatment — most weight is regained within one to two years without continued support
Treatment duration is set by a prescriber based on your response, tolerability and clinical circumstances, not a fixed calendar

Semaglutide has a half-life of roughly one week, which is why it works as a once-weekly injection. A single dose stays active in your body for approximately seven days, keeping appetite-regulating signals elevated between injections. That said, how long semaglutide lasts as a treatment is a separate question — and the answer depends on how long you take it and what happens when you stop. These are prescription-only medicines; a clinician assesses whether they are appropriate for you before any prescription is issued.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

What the evidence and clinical experience tell us about semaglutide's duration of action

Why does semaglutide last long enough for once-weekly dosing?

Most medicines clear your system within hours. Semaglutide works differently. Its molecular structure includes a fatty-acid chain that binds tightly to albumin, a protein in the blood, and this binding dramatically slows the rate at which it breaks down. The result is a half-life of close to seven days, meaning roughly half of each dose is still circulating a week later. That pharmacological feature is precisely what allows one injection to cover an entire week.

In practical terms, this means appetite suppression, the slowing of gastric emptying and the effects on blood sugar regulation do not switch off between doses. You are not getting a peak-and-trough effect in the same way you would with a twice-daily tablet. The Wegovy treatment overview explains how this steady action translates into real-world use. If you want to understand what happens to semaglutide specifically once it is inside your body at a cellular level, this page goes deeper on the pharmacokinetics.

Steady-state concentration (the point at which your body is absorbing and clearing semaglutide at the same rate) is reached after four to five weeks of weekly injections. This partly explains why results are not immediate; the medicine takes about a month to reach its full working level in your system.

How long do the weight-loss results actually last during treatment?

Results build gradually and continue accumulating for many months. In the STEP 1 clinical trial, published in the New England Journal of Medicine, participants using semaglutide 2.4 mg lost around 15% of their body weight on average over 68 weeks. The trajectory was not a straight line: most of the loss occurred in the first 60 weeks, with a plateau approaching as the body adjusted.

What this means in practice is that semaglutide does not deliver all its benefit in the first month or two. Patience matters. A question our prescribers hear regularly is whether slow early progress means the medicine is not working, more often, it reflects the dose titration phase, where the starting 0.25 mg dose is building toward maintenance. How long Wegovy takes to produce noticeable changes is worth reading if you are at that early stage.

There is also the question of semaglutide's duration across a full course of treatment. NICE recommends semaglutide (Wegovy) be used for a maximum of two years within a specialist weight management service, and advises reviewing whether to continue if less than 5% weight loss is achieved after six months on the maintenance dose. NICE's appraisal of semaglutide (TA875) sets out the full clinical recommendation. Whether a longer or shorter course suits you is a decision made with your prescriber, not a timer you set yourself.

What happens to the effects when you stop taking semaglutide?

This is the question most people find uncomfortable, but it deserves a straight answer. The appetite-suppressing effect of semaglutide does not persist after you stop. Once the medicine clears your system, the hormonal signals that had been moderating hunger return to their previous pattern. For most people, this means gradual weight regain.

Clinical evidence backs this up clearly. A follow-up study to STEP 1 showed that participants who stopped semaglutide regained most of the weight they had lost within one year of discontinuation, though they retained some benefit compared with placebo by the end of the follow-up period. This is not a failure of willpower; it reflects the biological reality that obesity involves persistent hormonal dysregulation, and removing the medicine removes the correction.

Understanding how long semaglutide remains detectable in your system after stopping can help set expectations around this transition. The half-life of approximately seven days means the medicine is largely cleared within five to seven weeks, though individual variation applies. If you are weighing up the longer-term picture for your own situation (including what happens around planned breaks such as surgery, pregnancy planning or simply payday timing when reordering feels awkward) that is exactly the kind of conversation to have with a prescriber before making any changes.

Does the format of semaglutide affect how long it lasts?

Wegovy is available as a weekly injection, and the MHRA approved a higher 7.2 mg single-dose pen in April 2026. The once-weekly rhythm remains the same regardless of the dose pen used; the half-life does not change with the higher strength. A separate licensed format exists for weight management in tablet form: the oral Wegovy tablet reaches its maintenance dose of 25 mg taken once daily, and because absorption is lower by mouth than by injection, the dosing frequency differs, but it is not a shorter-acting medicine in any clinically meaningful sense.

For a fuller picture of how the injection and tablet compare on timing, results and practical convenience, this guide to how long Wegovy's effects last covers both formats. If cost is a factor in your thinking about treatment duration, the Wegovy price comparison for the UK sets out the honest market context. When you are ready to discuss your own timeline with a clinician, speaking to our prescribers is a free first step with no obligation attached.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions